Progenics shifts Relistor marketing duties from Pfizer to Salix
February 08 2011
Progenics announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation, to Salix Pharmaceuticals, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.